Healthcare Services

Diabetes Diagnostics Market Outlook (2026–2030): Long-Term Insights

April 21, 2026April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Diabetes Diagnostics Market Be By 2030 Compared To Its 2026 Market Size?

The diabetes diagnostics market has experienced significant expansion in recent years. Its value is projected to climb from $27.31 billion in 2025 to $29.39 billion in 2026, at a compound annual growth rate (CAGR) of 7.6%. The historical increase can be linked to factors such as the rising incidence of diabetes, continued reliance on fingerstick blood glucose testing, the proliferation of hospital-based diagnostics, greater public awareness of glycemic control, and the expansion of diagnostic laboratories.

The diabetes diagnostics market is anticipated to show significant expansion over the next few years, with its size projected to reach $38.98 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3%. This expected growth during the forecast period is attributed to several factors, including the increased use of continuous glucose monitoring, the rising adoption of homecare diagnostics, technological improvements in biosensors, an increase in healthcare expenditure, and the broadening of digital health ecosystems. Notable trends for this period encompass the wider acceptance of continuous glucose monitoring, the integration of intelligent and connected diagnostic devices, a growing demand for home-based diabetes testing, an amplified focus on early diabetes screening programs, and breakthroughs in non-invasive glucose monitoring.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

What Significant Factors Are Influencing The Diabetes Diagnostics Market Expansion?

The increasing incidence of obesity is anticipated to fuel the expansion of the diabetes diagnostics market moving forward. Obesity is defined as an excessive accumulation of body fat that heightens the risk of various health conditions, including heart disease and diabetes. The growing prevalence of obesity is attributed to factors such as sedentary lifestyles, increased consumption of processed and high-calorie foods, genetic predisposition, and limited physical activity. Diabetes diagnostics assist in obesity management by identifying insulin resistance and glucose metabolism issues at an early stage, enabling timely interventions to prevent weight gain and related health complications. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government body, from 2023 to 2024, an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity, up from 64.0% in 2022 to 2023. Consequently, the escalating prevalence of obesity is driving the growth of the diabetes diagnostics market.

What Are The Key Segment Divisions In The Diabetes Diagnostics Market Segment Structure?

The diabetes diagnostics market covered in this report is segmented –

1) By Product Type: Blood Glucose Meters, Continuous Glucose Monitoring Devices, Lancets, Test Strips, Other Product Types

2) By Diabetes Type: Diabetes I, Diabetes Ii, Gestational Diabetes

3) By End-User: Hospitals, Diagnostic Centers, Homecare Settings, Other End-Users

Subsegments:

1) By Blood Glucose Meters: Traditional Blood Glucose Meters, Smart Blood Glucose Meters, Bluetooth-Enabled Blood Glucose Meters

2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems, Implantable CGM Systems, Flash Glucose Monitoring Devices

3) By Lancets: Single-Use Lancets, Multi-Use Lancets

4) By Test Strips: Standard Test Strips, Smart Test Strips

5) By Other Product Types: Hemoglobin A1c Testing Kits, Urine Glucose Test Strips, Blood Ketone Meters

What Trends Are Affecting The Direction Of The Diabetes Diagnostics Market?

Companies leading the diabetes diagnostics market are focusing on the development of innovative solutions, such as gestational diabetes diagnostics tools, to expand their product portfolios and address the rising demand for early detection and management of diabetes during pregnancy. A gestational diabetes diagnostic tool encompasses medical devices or tests utilized to identify and monitor gestational diabetes in pregnant individuals, typically involving blood glucose testing, like the oral glucose tolerance test (OGTT), to evaluate the body’s sugar processing efficiency throughout pregnancy. As an example, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, introduced its XpressGT RUO kit, a pioneering biosensor tool engineered for the detection of conditions related to insulin resistance, including gestational diabetes, endometriosis, and liver disease. This kit offers rapid results by measuring 2-hydroxybutyrate (2-HB) levels in venous blood and is compatible with standard clinical analyzers. This innovation seeks to provide early diagnostics, potentially improving outcomes for millions of patients globally.

Which Organizations Are Engaged In The Diabetes Diagnostics Market?

Major companies operating in the diabetes diagnostics market are F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Medtronic plc, DexCom Inc, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp, Bionime Corporation, Acon Laboratories Inc, Sinocare Inc, i‑SENS Inc, Prodigy Diabetes Care LLC, Rossmax International Ltd, Menarini Diagnostics s.r.l, Trividia Health Inc, EKF Diagnostics Holdings plc.

Get The Full Diabetes Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

Which Region Accounts For The Largest Portion Of The Diabetes Diagnostics Market?

North America was the largest region in the diabetes diagnostics market in 2025. The regions covered in the diabetes diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Diabetes Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report

Browse Through More Reports Similar to the Global Diabetes Diagnostics Market 2026, By The Business Research Company

Clinical Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Digital Diabetes Management Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

Point Of Care Glucose Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795